DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,993 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $50,997,000 | +5.0% | 197,440 | +3.0% | 2.84% | +4.0% |
| Q2 2022 | $48,579,000 | -22.0% | 191,619 | -9.8% | 2.73% | -2.3% |
| Q1 2022 | $62,302,000 | -17.4% | 212,394 | -7.3% | 2.79% | +0.4% |
| Q4 2021 | $75,413,000 | +20.3% | 229,211 | +11.3% | 2.78% | +20.7% |
| Q3 2021 | $62,709,000 | +14.1% | 205,982 | +0.6% | 2.30% | +15.1% |
| Q2 2021 | $54,939,000 | +28.9% | 204,720 | +8.1% | 2.00% | +13.7% |
| Q1 2021 | $42,615,000 | +24.7% | 189,331 | +23.1% | 1.76% | +26.1% |
| Q4 2020 | $34,170,000 | -20.7% | 153,822 | -23.1% | 1.40% | -27.5% |
| Q3 2020 | $43,093,000 | +20.7% | 200,124 | -0.9% | 1.93% | +8.3% |
| Q2 2020 | $35,717,000 | +31.8% | 201,987 | +3.2% | 1.78% | +4.5% |
| Q1 2020 | $27,100,000 | -18.6% | 195,797 | -9.7% | 1.70% | +8.2% |
| Q4 2019 | $33,285,000 | -11.9% | 216,866 | -17.1% | 1.57% | -19.6% |
| Q3 2019 | $37,800,000 | -0.7% | 261,719 | -1.7% | 1.96% | +0.6% |
| Q2 2019 | $38,062,000 | +10.5% | 266,315 | +2.1% | 1.94% | +3.6% |
| Q1 2019 | $34,447,000 | -10.6% | 260,926 | -30.2% | 1.88% | -27.3% |
| Q4 2018 | $38,544,000 | -14.9% | 373,776 | -10.3% | 2.58% | +8.3% |
| Q3 2018 | $45,293,000 | +10.6% | 416,828 | +0.5% | 2.38% | +2.4% |
| Q2 2018 | $40,940,000 | +42.5% | 414,877 | +41.4% | 2.33% | +34.6% |
| Q1 2018 | $28,727,000 | +16.5% | 293,400 | +10.4% | 1.73% | +11.7% |
| Q4 2017 | $24,664,000 | +19.5% | 265,715 | +10.5% | 1.55% | +6.2% |
| Q3 2017 | $20,634,000 | +4.5% | 240,550 | +2.8% | 1.46% | +6.3% |
| Q2 2017 | $19,752,000 | +4625.4% | 234,052 | +4706.0% | 1.37% | +4627.6% |
| Q1 2017 | $418,000 | +106.9% | 4,870 | +143.5% | 0.03% | +81.2% |
| Q2 2016 | $202,000 | – | 2,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |